`
`NOTE: This order is nonprecedential.
`United States Court of Appeals
`for the Federal Circuit
`______________________
`
`ALLERGAN, INC., SAINT REGIS MOHAWK TRIBE,
`Plaintiffs-Appellants
`
`v.
`
`TEVA PHARMACEUTICALS USA, INC., AKORN,
`INC., MYLAN PHARMACEUTICALS INC., MYLAN,
`INC.,
`Defendants-Appellees
`______________________
`
`2018-1130
`______________________
`
`Appeal from the United States District Court for the
`Eastern District of Texas in No. 2:15-cv-01455-WCB,
`Circuit Judge William C. Bryson.
`______________________
`
`ON MOTION
`______________________
`
`Before LINN, Circuit Judge.
`O R D E R
` Appellants move for an order directing Appellees to
`(1) “continue providing Appellants with all communica-
`tions with [the Food and Drug Administration (FDA)]
`related to their [Abbreviated New Drug Applications]
`within seven days of when they are sent or received, while
`
`
`
`Case 2:15-cv-01455-WCB Document 549 Filed 01/03/18 Page 2 of 2 PageID #: 26572
`
`
`
` 2
`
` ALLERGAN, INC. v. TEVA PHARMACEUTICALS USA, INC.
`
`this appeal is pending” and (2) if Appellees receive FDA
`approval, “notify Appellants the day such approval is
`received.” Appellees oppose. Appellants reply.
`Upon consideration thereof,
`IT IS ORDERED THAT:
`The motion is denied.
`
`FOR THE COURT
`
` /s/ Peter R. Marksteiner
`Peter R. Marksteiner
`Clerk of Court
`
`s32
`
`